Viibryd and Type 2 diabetes - a phase IV clinical study of FDA data

Summary:

Type 2 diabetes is reported as a side effect among people who take Viibryd (vilazodone hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for 1 - 2 years also take Xyrem, and have Narcolepsy.

The phase IV clinical study analyzes which people have Type 2 diabetes when taking Viibryd. It is created by eHealthMe based on reports of 10,186 people who have side effects when taking Viibryd from the FDA, and is updated regularly.

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.

What is Type 2 diabetes?

Type 2 diabetes is found to be associated with 1,431 drugs and 2,342 conditions by eHealthMe. Check the latest studies of Type 2 diabetes.

On Apr, 15, 2026

10,186 people reported to have side effects when taking Viibryd.
Among them, 14 people (0.14%) have Type 2 diabetes.

Among these 14 people:

How long have people been on Viibryd when they have Type 2 diabetes? *

What is the gender of people who have Type 2 diabetes when taking Viibryd? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Type 2 diabetes when taking Viibryd? *

What are other drugs people take besides Viibryd? *

What are other side effects people have besides Type 2 diabetes? *

High Blood Pressure: 5 people, 35.71%
Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 28.57%
Headache (pain in head): 4 people, 28.57%
Weight Decreased: 3 people, 21.43%
Rickets (softening of bones): 3 people, 21.43%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 14.29%
Gestational Diabetes (diabetes in pregnancy): 2 people, 14.29%
Migraine (headache): 2 people, 14.29%
Live Birth: 2 people, 14.29%
Iron Deficiency Anaemia: 2 people, 14.29%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 50.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 21.43%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 14.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.14%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 7.14%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 7.14%
Drowsiness: 1 person, 7.14%
Gout (uric acid crystals building up in the body): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Viibryd and have Type 2 diabetes?

- Check whether Type 2 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viibryd:

Viibryd (11,106 reports)

Type 2 diabetes treatments and more:

Type 2 diabetes (391,579 reports)

Browse all side effects of Viibryd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 2 diabetes:

Type 2 diabetes (1,431 drugs)

Browse all the conditions that are associated with Type 2 diabetes:

Type 2 diabetes (2,342 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vilazodone hydrochloride (the active ingredients of Viibryd) and Viibryd (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.